02 November 2021>: Articles
Glucocorticoids Induce Partial Remission of Focal Segmental Glomerulosclerosis but Not Interstitial Nephritis in COVID-19 Acute Kidney Injury in an APOL1 Low-Risk Genotype White Patient
Challenging differential diagnosis, Rare coexistence of disease or pathology
Piotr J. Nowak A* , Joanna Forycka B , Natalia Cegielska B , Karolina Harendarz B , Małgorzata Wągrowska-Danilewicz B , Marian Danilewicz B , Tomasz Płoszaj B , Maciej Borowiec C , Rafał Wlazeł B , Michał Nowicki DDOI: 10.12659/AJCR.933462
Am J Case Rep 2021; 22:e933462
Figure 1. A decrease of serum creatinine and C-reactive protein during glucocorticoid treatment. Initial dexamethasone dose of 6 mg/day was followed by 16 mg/day for 6 days then it was gradually reduced to 8, 4 and 2 mg/day. 2 units of Covid-19 convalescent plasma was transfused on day 3. Methylprednisolone pulse was administered after obtaining first kidney biopsy results.